1,4-disubstituted anthracene antitumor agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Anthracene derivatives are investigated for their potential anti-cancer properties.
• Cytotoxicity is influenced by the substitution pattern on the anthracene core.
• Structure-activity relationships are crucial for developing effective anti-cancer agents.

Purpose of the Study:

• To synthesize novel 1,4-disubstituted anthracenes.
• To evaluate and compare the cytotoxicity of 1,4- and 9,10-disubstituted anthracenes against various cancer cell lines.
• To explore the correlation between DNA binding affinity and anti-cancer potency.

Main Methods:

• Synthesis of three series of 1,4-disubstituted anthracenes with specific side chains: [[(dimethylamino)ethyl]amino]methyl, N-[(dimethylamino)ethyl]carbamoyl, and carboxaldehyde (4,5-dihydro-1H-imidazol-2-yl)hydrazone.
• Cytotoxicity assays using a panel of human cancer cells (myeloma, melanoma, colon, lung) and murine leukemia cells (L1210 sensitive and multidrug-resistant).
• Measurement of DNA transition melt temperatures to assess DNA binding affinity.

Main Results:

• The 1,4-diamide derivative exhibited greater potency against the tumor cell panel compared to its 9,10-isomer.
• The 1,4-diamine and 1,4-hydrazone derivatives were less potent than their respective 9,10-isomers.
• The 1,4-hydrazone showed activity in P388 leukemia mouse models but not in L1210 leukemia.
• A positive correlation was observed between increased anti-cancer potency and a higher increase in DNA transition melt temperature.

Conclusions:

• The substitution position (1,4- vs. 9,10-) significantly impacts the cytotoxic activity of anthracenes.
• The N-[(dimethylamino)ethyl]carbamoyl side chain at the 1,4-position confers superior anti-cancer activity compared to its 9,10-isomer.
• DNA binding affinity appears to be a contributing factor to the anti-cancer efficacy of these anthracene compounds.